← Back to Search

Provider Comparison for Acute Pain

N/A
Waitlist Available
Led By Kevin L Kraemer, MD
Research Sponsored by University of Pittsburgh
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at 1, 6, and 12 months after initial qualifying clinic visit
Awards & highlights

Study Summary

This trial will test whether two behavioral interventions can reduce the likelihood of prescribing opioids for acute pain, and whether this leads to improved pain and function for patients.

Eligible Conditions
  • Acute Pain
  • Musculoskeletal Pain
  • Headache

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at 1, 6, and 12 months after initial qualifying clinic visit
This trial's timeline: 3 weeks for screening, Varies for treatment, and assessed at 1, 6, and 12 months after initial qualifying clinic visit for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Initial Opioid Prescription
Secondary outcome measures
Change in Patient Reported Pain and Function
Chronic opioid therapy at 12 months
Chronic opioid therapy at 3 months
+5 more

Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: Guideline + Provider Comparison (PC)Experimental Treatment2 Interventions
Providers will receive monthly feedback via e-mail on their status in regards to initial opioid prescriptions for acute pain, adherence to safe opioid prescribing guidelines, and proportion of patients started on opioids f or acute pain who transition to chronic opioid therapy (> 3 months). Providers in the lowest decile overall for proportion of patients with initial opioid prescriptions , unsafe opioid prescribing, and transition to chronic opioid therapy (> 3 months) will be given positive feedback for providing high quality, evidence-based care to their patients with acute pain. Providers outside the lowest decile will be notified they are outside the high quality, evidence-based care range and will be provided with their proportions compared to the high performers.
Group II: Guideline + Opioid Justification (OJ)Experimental Treatment2 Interventions
Providers will be required asked to enter a free text justification for their decision to prescribe an opioid analgesic for the acute pain condition. The provider will be notified that the justification provided will be visible in the Epic EHR. The provider has the option of entering a justification or not. If no justification is entered, nothing will be entered into the record (i.e., the Opioid Justification area in the encounter record will be left blank). The provider does not need to enter a justification if they choose to cancel the opioid prescription.
Group III: Guideline + OJ + PCExperimental Treatment3 Interventions
This arm will include the guideline, opioid justification, and provider comparison described above.
Group IV: Usual Care/GuidelineActive Control1 Intervention
The Usual Care group (also known as the Guideline group) follows the recent Center for Disease Control (CDC) guidelines and, when triggered by an opioid prescription during a qualifying visit, will be delivered real-time in a short checklist of recommendations to: 1) check the state-specific Prescription Drug Monitoring Program; 2) assess risk factors for opioid-related harms (e.g., history of substance use disorder, history of mental health problems, benzodiazepine use); 3) avoid extended-release or long-acting opioids; 4) use a low dose of immediate-release opioid for short period of time (3-7 days); and 5) consider non-opioid management such as acetaminophen, non-steroidal anti-inflammatory agents (NSAIDS), and physical therapy. Epic EHR order sets will be linked to enable easing ordering of non-opioid therapy.

Find a Location

Who is running the clinical trial?

University of PittsburghLead Sponsor
1,722 Previous Clinical Trials
16,320,370 Total Patients Enrolled
7 Trials studying Acute Pain
1,285 Patients Enrolled for Acute Pain
University of UtahOTHER
1,099 Previous Clinical Trials
1,756,123 Total Patients Enrolled
3 Trials studying Acute Pain
1,089 Patients Enrolled for Acute Pain
Patient-Centered Outcomes Research InstituteOTHER
551 Previous Clinical Trials
29,974,882 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care
Kevin Kraemer 2018. "Provider-Targeted Behavioral Interventions to Prevent Unsafe Opioid Prescribing for Acute Pain in Primary Care". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03537573.
All > Acute Pain
~3428 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top